Literature DB >> 18404481

The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.

Silvia Deaglio1, Fabio Malavasi.   

Abstract

Human CD38 is the mammalian prototype of a family of phylogenetically conserved proteins which share structural similarities and enzymatic activities involved in the production of an intracellular second messenger with calcium mobilizing effects. Engagement of CD38 by agonistic monoclonal antibodies and the CD31 ligand initiates a cytoplasmic signaling cascade involving tyrosine phosphorylation of the proto-oncogene c-cbl and of the extracellular regulated kinase 1 of 2 complex. Further requirements for signal transduction include a privileged localization within the cholesterol-rich areas of the plasma membrane and physical association with specialized surface receptors. CD38-mediated signals are crucial in heterotypic cell adhesion and migration as well as in the activation of proliferation/survival programs by normal and neoplastic cells. Here we review the most recent literature on this complex topic and attempt to formulate a single model reconciling the enzymatic and receptorial activities of CD38.

Entities:  

Year:  2006        PMID: 18404481      PMCID: PMC2096639          DOI: 10.1007/s11302-006-9002-6

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  109 in total

Review 1.  Alerting and tuning the immune response by extracellular nucleotides.

Authors:  Andrea la Sala; Davide Ferrari; Francesco Di Virgilio; Marco Idzko; Johannes Norgauer; Giampiero Girolomoni
Journal:  J Leukoc Biol       Date:  2003-03       Impact factor: 4.962

2.  Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.

Authors:  A Funaro; G C Spagnoli; C M Ausiello; M Alessio; S Roggero; D Delia; M Zaccolo; F Malavasi
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

3.  CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells.

Authors:  Loredana Frasca; Giorgio Fedele; Silvia Deaglio; Cristina Capuano; Raffaella Palazzo; Tiziana Vaisitti; Fabio Malavasi; Clara Maria Ausiello
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

4.  The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen.

Authors:  R F Todd; J A Roach; M A Arnaout
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

5.  Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes.

Authors:  G S Kansas; G S Wood; T F Tedder
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

6.  Chromosome assignment of monoclonal antibody-defined determinants on human leukemic cells.

Authors:  F Katz; S Povey; M Parkar; C Schneider; R Sutherland; K Stanley; E Solomon; M Greaves
Journal:  Eur J Immunol       Date:  1983-12       Impact factor: 5.532

7.  Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells.

Authors:  F Malavasi; F Caligaris-Cappio; C Milanese; P Dellabona; P Richiardi; A O Carbonara
Journal:  Hum Immunol       Date:  1984-01       Impact factor: 2.850

Review 8.  The human T-cell receptor.

Authors:  S C Meuer; O Acuto; T Hercend; S F Schlossman; E L Reinherz
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

9.  Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets.

Authors:  T Hercend; J Ritz; S F Schlossman; E L Reinherz
Journal:  Hum Immunol       Date:  1981-11       Impact factor: 2.850

10.  CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.

Authors:  Silvia Deaglio; Andrea Capobianco; Luciana Bergui; Jan Dürig; Fortunato Morabito; Ulrich Dührsen; Fabio Malavasi
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

View more
  8 in total

Review 1.  CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.

Authors:  Fabio Malavasi; Silvia Deaglio; Enza Ferrero; Ada Funaro; Jaime Sancho; Clara M Ausiello; Erika Ortolan; Tiziana Vaisitti; Mercedes Zubiaur; Giorgio Fedele; Semra Aydin; Elena V Tibaldi; Ilaria Durelli; Riccardo Lusso; Franco Cozno; Alberto L Horenstein
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 2.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

Review 3.  Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.

Authors:  Silvia Deaglio; Simon C Robson
Journal:  Adv Pharmacol       Date:  2011

4.  Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells.

Authors:  Miaoqing Shen; Andrew Yen
Journal:  Oncology       Date:  2009-01-06       Impact factor: 2.935

5.  Genome-Wide Meta-Analysis of Blood Pressure Response to β1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).

Authors:  Sonal Singh; Helen R Warren; Timo P Hiltunen; Caitrin W McDonough; Nihal El Rouby; Erika Salvi; Zhiying Wang; Tatiana Garofalidou; Frej Fyhrquist; Kimmo K Kontula; Valeria Glorioso; Roberta Zaninello; Nicola Glorioso; Carl J Pepine; Patricia B Munroe; Stephan T Turner; Arlene B Chapman; Eric Boerwinkle; Julie A Johnson; Yan Gong; Rhonda M Cooper-DeHoff
Journal:  J Am Heart Assoc       Date:  2019-08-19       Impact factor: 5.501

Review 6.  The Extracellular NADome Modulates Immune Responses.

Authors:  Valentina Audrito; Vincenzo Gianluca Messana; Lorenzo Brandimarte; Silvia Deaglio
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

Review 7.  NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.

Authors:  Valentina Audrito; Vincenzo Gianluca Messana; Silvia Deaglio
Journal:  Front Oncol       Date:  2020-03-19       Impact factor: 6.244

Review 8.  Is Oxytocin "Nature's Medicine"?

Authors:  C Sue Carter; William M Kenkel; Evan L MacLean; Steven R Wilson; Allison M Perkeybile; Jason R Yee; Craig F Ferris; Hossein P Nazarloo; Stephen W Porges; John M Davis; Jessica J Connelly; Marcy A Kingsbury
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.